Cargando…
Nutritional Management and Biochemical Outcomes during the Immediate Phase after Liver Transplant for Methylmalonic Acidemia
Methylmalonic acidemia (MMA) is caused by a deficiency of methyl-malonyl-CoA mutase. It is a multisystemic condition with poor clinical outcomes characterized by frequent metabolic decompensation with acidosis, hyperammonemia and encephalopathy. Restriction of intact protein and supplementation with...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599551/ https://www.ncbi.nlm.nih.gov/pubmed/33003354 http://dx.doi.org/10.3390/nu12102976 |
_version_ | 1783602902771695616 |
---|---|
author | Siegel, Casey Arnon, Ronen Florman, Sander Bucuvalas, John Oishi, Kimihiko |
author_facet | Siegel, Casey Arnon, Ronen Florman, Sander Bucuvalas, John Oishi, Kimihiko |
author_sort | Siegel, Casey |
collection | PubMed |
description | Methylmalonic acidemia (MMA) is caused by a deficiency of methyl-malonyl-CoA mutase. It is a multisystemic condition with poor clinical outcomes characterized by frequent metabolic decompensation with acidosis, hyperammonemia and encephalopathy. Restriction of intact protein and supplementation with amino acid-based formula play an important role in its management. Recently, liver transplant (LT) became a treatment option for MMA patients. However, there has been no current consensus on the post-operative nutrition management for MMA patients undergoing transplant, particularly during the initial phase of recovery period with catabolic stressors. We performed a retrospective analysis of clinical and nutritional management as well as biochemical profiles before and after LT in five patients with MMA. Through this study, we observed significant improvement of MMA-associated metabolites after LT. MMA patients were able to tolerate increased intact protein intake post-operatively. At least 1–1.5 g/kg/day of total protein during the acute phase after transplant may be tolerated without worsening of the metabolite levels. This information provides a guide in how to nutritionally manage MMA after LT. |
format | Online Article Text |
id | pubmed-7599551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75995512020-11-01 Nutritional Management and Biochemical Outcomes during the Immediate Phase after Liver Transplant for Methylmalonic Acidemia Siegel, Casey Arnon, Ronen Florman, Sander Bucuvalas, John Oishi, Kimihiko Nutrients Article Methylmalonic acidemia (MMA) is caused by a deficiency of methyl-malonyl-CoA mutase. It is a multisystemic condition with poor clinical outcomes characterized by frequent metabolic decompensation with acidosis, hyperammonemia and encephalopathy. Restriction of intact protein and supplementation with amino acid-based formula play an important role in its management. Recently, liver transplant (LT) became a treatment option for MMA patients. However, there has been no current consensus on the post-operative nutrition management for MMA patients undergoing transplant, particularly during the initial phase of recovery period with catabolic stressors. We performed a retrospective analysis of clinical and nutritional management as well as biochemical profiles before and after LT in five patients with MMA. Through this study, we observed significant improvement of MMA-associated metabolites after LT. MMA patients were able to tolerate increased intact protein intake post-operatively. At least 1–1.5 g/kg/day of total protein during the acute phase after transplant may be tolerated without worsening of the metabolite levels. This information provides a guide in how to nutritionally manage MMA after LT. MDPI 2020-09-29 /pmc/articles/PMC7599551/ /pubmed/33003354 http://dx.doi.org/10.3390/nu12102976 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Siegel, Casey Arnon, Ronen Florman, Sander Bucuvalas, John Oishi, Kimihiko Nutritional Management and Biochemical Outcomes during the Immediate Phase after Liver Transplant for Methylmalonic Acidemia |
title | Nutritional Management and Biochemical Outcomes during the Immediate Phase after Liver Transplant for Methylmalonic Acidemia |
title_full | Nutritional Management and Biochemical Outcomes during the Immediate Phase after Liver Transplant for Methylmalonic Acidemia |
title_fullStr | Nutritional Management and Biochemical Outcomes during the Immediate Phase after Liver Transplant for Methylmalonic Acidemia |
title_full_unstemmed | Nutritional Management and Biochemical Outcomes during the Immediate Phase after Liver Transplant for Methylmalonic Acidemia |
title_short | Nutritional Management and Biochemical Outcomes during the Immediate Phase after Liver Transplant for Methylmalonic Acidemia |
title_sort | nutritional management and biochemical outcomes during the immediate phase after liver transplant for methylmalonic acidemia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599551/ https://www.ncbi.nlm.nih.gov/pubmed/33003354 http://dx.doi.org/10.3390/nu12102976 |
work_keys_str_mv | AT siegelcasey nutritionalmanagementandbiochemicaloutcomesduringtheimmediatephaseafterlivertransplantformethylmalonicacidemia AT arnonronen nutritionalmanagementandbiochemicaloutcomesduringtheimmediatephaseafterlivertransplantformethylmalonicacidemia AT flormansander nutritionalmanagementandbiochemicaloutcomesduringtheimmediatephaseafterlivertransplantformethylmalonicacidemia AT bucuvalasjohn nutritionalmanagementandbiochemicaloutcomesduringtheimmediatephaseafterlivertransplantformethylmalonicacidemia AT oishikimihiko nutritionalmanagementandbiochemicaloutcomesduringtheimmediatephaseafterlivertransplantformethylmalonicacidemia |